Ginkgo Bioworks Holdings, Inc.
Could not find a ticker for this position, may be a filing error
A maker of cell-engineering tools, Ginkgo Bioworks designs custom organisms and cells for pharmaceutical, agricultural, and industrial clients, using lab automation and AI models. Its Canopy and Horizon biosecurity platforms monitor wastewater and other samples for government customers to spot emerging biological threats. Founded in 2008 by five MIT scientists who wanted to make biology easier to engineer, the company took its name from the ginkgo tree, an ancient "living fossil" unchanged for tens of millions of years.
Warrant (expires 08/01/202)
Granted 105.3K · Sold 1.99M
Granted 307.3K · Sold 1.43M
Granted 307.3K · Sold 1.43M
Granted 105.3K
Granted 425.9K · Sold 3.81M
Granted 116.1K · Bought 297.6K
Granted 105.3K
Granted 116.1K · Bought 625.0K
Granted 1.15M · Sold 556.6K
Granted 477.5K · Sold 224.6K
Granted 116.1K · Sold 33.5K
Granted 24.1K
Granted 116.1K
Granted 10.8K
Granted 10.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Dekkers Marijn EDirector · 3 transactions | -24.3% | 5.90Mas of Jun 2024 | 105.3K | — | 1.99M |
| Canton Barry10% owner · 43 transactions | -97% | 775.0K | 307.3K | — | 1.43M |
| Shetty Reshma P.See remarks, Director, 10% owner · 43 transactions | -97.2% | 775.0K | 307.3K | — | 1.43M |
| Belldegrun ArieDirector · 1 transaction | +17.9% | 694.9Kas of Jun 2024 | 105.3K | — | — |
| Kelly Jason RSee remarks, Director · 40 transactions | -95.8% | 316.5K | 425.9K | — | 3.81M |
| Sloan HarryDirector · 5 transactions | -35.5% | 271.4Kas of Jun 2025 | 116.1K | 297.6K | — |
| Kewalramani ReshmaDirector · 1 transaction | +130.4% | 186.0Kas of Jun 2024 | 105.3K | — | — |
| Sankar ShyamDirector · 3 transactions | -95.8% | 72.4Kas of Jun 2025 | 116.1K | 625.0K | — |
| Dmytruk Mark E.See remarks · 97 transactions | -95.4% | 52.1Kas of May 2025 | 1.15M | — | 556.6K |
| Coen Steven P.See remarks · 71 transactions | — | 50.7K | 477.5K | — | 224.6K |
| Henry Christian ODirector · 7 transactions | -98.1% | 24.3K | 116.1K | — | 33.5K |
| Kosuri SriDirector · 1 transaction | — | 24.1Kas of Jun 2025 | 24.1K | — | — |
| Hannan Kathy HopinkahDirector · 2 transactions | +200.1% | 15.0Kas of Jun 2025 | 116.1K | — | — |
| Fubini RossDirector · 1 transaction | — | 10.8Kas of Jun 2025 | 10.8K | — | — |
| Potter Myrtle SDirector · 1 transaction | — | 10.8Kas of Jun 2025 | 10.8K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -8.55M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.